Zhou J F, He M D, Li M Z, Yang W, Tang J Z, Sheng G, Zhu H F, Shao J F, Yang J
Integrated traditional chinese medicine and western medicine institution, Tongji hospital, Tongji Medical University, Wuhan.
J Tongji Med Univ. 1994;14(3):188-92. doi: 10.1007/BF02886805.
Immunologically mediated aplastic anemia in mice were used as animal models to study the the curative effect of Zaizhang-I in term of the changes of two pathogenetic aspects in aplastic mice, namely the deficiency of hematopoietic stem cells and the disturbance of immunology. Our results demonstrated that in aplastic mice, after treatment by Zaizhang-I, the loss of mature hematopoietic cells (WBC, RBC, Plt) were reduced, and marrow cellular cytosis, and their clinical findings were improved, indicating a partial remission. The present data show that its curative mechanism lies in the action of promoting the recovery of colony forming unit-spleen (CFU-S) and reversing immunologically-induced plasma colony forming unit granulocyte/macrophage (CFU-GM) inhibitory activity. Natural killer cells activity (Nka) and interleukin-2, tumor necrosis factors (TNF) were also so examined to further understand the mechanism by which Zaizhang-I reverse plasma hematopoietic activity.
以免疫介导的小鼠再生障碍性贫血作为动物模型,从再生障碍性小鼠造血干细胞缺乏和免疫紊乱这两个发病机制方面的变化来研究再障-I号的疗效。我们的结果表明,在再生障碍性小鼠中,再障-I号治疗后,成熟造血细胞(白细胞、红细胞、血小板)的损失减少,骨髓细胞增多,临床症状改善,表明有部分缓解。目前的数据表明其治疗机制在于促进脾集落形成单位(CFU-S)恢复以及逆转免疫诱导的血浆粒系/巨噬系集落形成单位(CFU-GM)抑制活性的作用。还检测了自然杀伤细胞活性(Nka)以及白细胞介素-2、肿瘤坏死因子(TNF),以进一步了解再障-I号逆转血浆造血活性的机制。